1. Mycobacterium tuberculosis disease associates with higher HIV-1-specific antibody responses
- Author
-
Bukola Adeoye, Lydia Nakiyingi, Yvetane Moreau, Ethel Nankya, Alex J. Olson, Mo Zhang, Karen R. Jacobson, Amita Gupta, Yukari C. Manabe, Mina C. Hosseinipour, Johnstone Kumwenda, and Manish Sagar
- Subjects
Immunology ,Immune response ,Microbiology ,Science - Abstract
Summary: Mycobacterium tuberculosis (Mtb) is the most common infection among people with HIV (PWH). Mtb disease-associated inflammation could affect HIV-directed immune responses in PWH. We show that HIV antibodies are broader and more potent in PWH in the presence as compared to the absence of Mtb disease. With co-existing Mtb disease, the virus in PWH also encounters unique antibody selection pressure. The Mtb-linked HIV antibody enhancement associates with specific mediators important for B cell and antibody development. This Mtb humoral augmentation does not occur due to cross-reactivity, a generalized increase in all antibodies, or differences in duration or amount of antigen exposure. We speculate that the co-localization of Mtb and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies. PWH’s Mtb disease status has implications for the future use of HIV broadly neutralizing antibodies as prophylaxis or treatment and the induction of better humoral immunity.
- Published
- 2023
- Full Text
- View/download PDF